Casebia Therapeutics

Casebia Therapeutics is a joint venture between CRISPR Therapeutics and Bayer AG, focused on discovering, developing and commercializing new CRISPR/Cas9-based breakthrough therapeutics to treat blood disorders, blindness, and heart disease

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical joint venture

Model

01Company Overview

Casebia Therapeutics is a joint venture between CRISPR Therapeutics and Bayer AG, focused on discovering, developing and commercializing new CRISPR/Cas9-based breakthrough therapeutics to treat blood disorders, blindness, and heart disease.

02Backed By1 investor

LbLeaps by Bayer→

03Similar Companies